Omega-3-acid ethyl esters – Dose-dependent increased risk of atrial fibrillation in certain patients
08/11/2023
Medicines for human use
Direct healthcare professional communication (DHPC)
Omega-3-acid ethyl ester medicines: dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors